- Home
- IMRN vs SCNX Comparison
IMRN vs SCNX Comparison
Compare IMRN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SCNX
- Stock Information
- Founded
- IMRN 1994
- SCNX 2010
- Country
- IMRN Australia
- SCNX United States
- Employees
- IMRN N/A
- SCNX N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- IMRN Health Care
- SCNX Health Care
- Exchange
- IMRN Nasdaq
- SCNX Nasdaq
- Market Cap
- IMRN 15.0M
- SCNX 59.2M
- IPO Year
- IMRN N/A
- SCNX 2020
- Fundamental
- Price
- IMRN $1.96
- SCNX $7.58
- Analyst Decision
- IMRN Strong Buy
- SCNX
- Analyst Count
- IMRN 1
- SCNX 0
- Target Price
- IMRN $5.00
- SCNX N/A
- AVG Volume (30 Days)
- IMRN 6.1K
- SCNX 13.8K
- Earning Date
- IMRN 12-31-2024
- SCNX 02-10-2025
- Dividend Yield
- IMRN N/A
- SCNX N/A
- EPS Growth
- IMRN N/A
- SCNX N/A
- EPS
- IMRN N/A
- SCNX 3.55
- Revenue
- IMRN $3,271,194.00
- SCNX N/A
- Revenue This Year
- IMRN N/A
- SCNX $1,085.75
- Revenue Next Year
- IMRN N/A
- SCNX N/A
- P/E Ratio
- IMRN N/A
- SCNX $3.23
- Revenue Growth
- IMRN 171.67
- SCNX 166.67
- 52 Week Low
- IMRN $1.59
- SCNX $3.69
- 52 Week High
- IMRN $5.96
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- IMRN 45.89
- SCNX N/A
- Support Level
- IMRN $2.05
- SCNX N/A
- Resistance Level
- IMRN $2.23
- SCNX N/A
- Average True Range (ATR)
- IMRN 0.17
- SCNX 0.00
- MACD
- IMRN -0.00
- SCNX 0.00
- Stochastic Oscillator
- IMRN 29.69
- SCNX 0.00
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.